Product Information
CHEST CONG RLF PE 400-10 MG TB is a generic product labeled by Rugby Laboratories, priced at $0.0883 per EA under NDC 00536130908. Its NADAC has been published 262 times since Jun 23, 2021.
Strength
400; 10 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536130908
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/9/2020
Pharmacological Classes
Price Statistics
The NADAC for CHEST CONG RLF PE 400-10 MG TB has been published 262 times since Jun 23, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0883 per EA |
|---|---|
| All-time high | $0.0937 (Mar 16, 2022) |
| All-time low | $0.0697 (Dec 21, 2022) |
| 52-week high | $0.0883 |
| 52-week low | $0.0740 |
| Median price | $0.0816 |
| Average price | $0.0816 |
| Largest weekly change | +16.4% (Feb 22, 2023) |
| Weeks tracked | 262 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CHEST CONG RLF PE 400-10 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CHEST CONG RLF PE 400-10 MG TB, manufactured by Rugby Laboratories, is $0.0883 per EA (NDC 00536130908), effective Jun 24, 2026.
How has the price of CHEST CONG RLF PE 400-10 MG TB changed over time?
Over the history we have for it, the NADAC for CHEST CONG RLF PE 400-10 MG TB has held within roughly two percent of its current level. It has been tracked across 262 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for CHEST CONG RLF PE 400-10 MG TB?
Since Jun 23, 2021, the NADAC for CHEST CONG RLF PE 400-10 MG TB has ranged from a low of $0.0697 (Dec 21, 2022) to a high of $0.0937 (Mar 16, 2022), with a median of $0.0816 per EA.
Are there cheaper alternatives to CHEST CONG RLF PE 400-10 MG TB?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SM CHEST CONG RELIEF PE CAPLET, is $0.0697 per EA — about 21% below CHEST CONG RLF PE 400-10 MG TB.
Who manufactures CHEST CONG RLF PE 400-10 MG TB?
CHEST CONG RLF PE 400-10 MG TB (NDC 00536130908) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification